Tracker

ETF universe handoff

Opening ETF evidence benchSynchronizing prices, risk metrics, holdings coverage, and source lineage

Company context

JD Health International, Inc.

HKEX:6618

Drugstore Chains · benchmarked against Retail Trade inside the KWEB constituent company universe.

Active tabFinancial reports

Current readMixed

Last close37.44

1M return-0.90%

Open symbol page Watchlist context

OverviewVerdict, thesis map, and valuation setup.FundamentalsDrivers, trajectory, and business quality.Financial reportsStatement tables, sorting, filtering, and acceleration.Ex-ante forecastTarget price, dividend yield, and total return by horizon.FactorsCompany factor exposure, rank, and universe context.Market viewMomentum, catalysts, charts, and symbol packet.AttributionLarge-move causes, residuals, and research backlog.OwnershipSEC 13F holder flow, crowding, and manager changes.PeersPeer heatmap and closest comparables.

Tab scope

Raw financial statements

Financial reports

Source and lookbackStored financial report rows12 report snapshots; latest report Apr 28, 11:27 AM GMT+8.

Sample and caveat27 reported metrics across 4 sections.Use this tab for its stated job; heavier model packets stay on their own tabs.

Traditional statement tables

Financial reports

12 reports · latest Apr 28, 11:27 AM GMT+8

Distinct report rows12

Sections4

Metrics shown27of 28 tracked

Coverage96%

CompanyJD Health International, Inc.

Overview scoring

Fundamental overview

59/100 blended · 85/100 confidence · benchmark Closest peers

Blended fundamental score: Earnings 56/100; Cash flow 66/100; Balance sheet 61/100; Valuation 48/100.

Broad comparison

Cohort scorecard

Coverage-adjusted score with thinner cohorts automatically down-weighted

Cohort scorecard: Closest peers 61/100; Retail Trade 60/100; KWEB constituent company universe 52/100.

Selected company rank

Rank and percentile

Confidence-adjusted standing inside each cohort

Rank and percentile: Closest peers #5 of 13; Retail Trade #4 of 5; KWEB constituent company universe #20 of 33.

Section scoring matrix

Earnings, cash flow, balance sheet, and valuation

Heatmap score by cohort and statement section

Section scoring matrix: Closest peers Earnings 58/100; Cash flow 69/100; Balance sheet 62/100; Valuation 50/100.

Sort byFilter metrics

Specialist report review

Quant, PM, and risk-manager reads

Deterministic review lanes from stored report metrics

Quant review

Favorable acceleration7/15

Operating income TTM has the largest second-order move at -156.91%. 7 metrics are accelerating favorably and 8 are decelerating.

Fundamental PM review

Growth and cash quality2/5

EPS TTM is 0.23 with -87.14% latest change. The PM lane checks revenue, EPS, cash flow, and margin confirmation together.

Risk manager review

Risk controls stableNo active flags

Debt / Equity is 0.01 with Need 2 reports latest change. The risk lane checks leverage, liquidity, and cash-yield deterioration.

Indexed report history

Financial report trend chart

First visible report = 100

Financial report trend chart: Total revenue 10.2B; Operating income TTM 528.5M; Operating margin +5.17%; EPS TTM 0.23.

Second order change

Acceleration chart

Favorable acceleration means the latest move improved versus the prior move

Acceleration chart: Total revenue -100.57%; Operating income TTM -156.91%; Operating margin -49.65%; EPS TTM -100.84%.

PM / risk lens

Risk and quality radar

Directional score from change and acceleration

Risk and quality radar: Growth 25/100; Cash 33/100; Quality 52/100; Balance 50/100; Valuation 88/100.

Earnings

Metric trend table

10 of 10 metrics shown

Metric	Latest	Change	Acceleration	Trend	Samples
Total revenueRevenue	10.2B	-87.16%-69.4B	-100.57%-78.9B	decelerating	12
Revenue quarterRevenue	5.5B	Need 2 reportsNeed 2 reports	Need 3 reportsNeed 3 reports	stable	1
Revenue next quarterRevenue	6.2B	Need 2 reportsNeed 2 reports	Need 3 reportsNeed 3 reports	stable	1
Operating income TTMEarnings	528.5M	-87.15%-3.6B	-156.91%-5.3B	decelerating	12
Operating marginProfitability	+5.17%	+0.03%Flat	-49.65%-1.71 pts	decelerating	12
EPS TTMEarnings	0.23	-87.14%-1.59	-100.84%-1.81	decelerating	12
EPS next quarterEarnings	0.17	Need 2 reportsNeed 2 reports	Need 3 reportsNeed 3 reports	stable	1
Gross marginQuality	+24.78%	+4.10%+0.98 pts	+0.09%+0.06 pts	improving	11
Net marginQuality	+7.32%	+0.94%+0.07 pts	-0.39%-0.03 pts	stable	11
Gross-to-net conversionQuality	+29.54%	FlatFlat	+3.04%+0.93 pts	accelerating	12

Historical statement rows

Earnings report history

12 dated rows

Snapshot date	Total revenue	Revenue quarter	Revenue next quarter	Operating income TTM	Operating margin	EPS TTM	EPS next quarter	Gross margin	Net margin	Gross-to-net conversion
Jan 4, 2021	21.8B	—	—	386M	+1.77%	-6.12	—	+25.37%	-89.37%	-352.27%
Jul 5, 2021	28.5B	—	—	-735.6M	-2.58%	-4.44	—	+24.77%	-49.60%	-200.27%
Jan 3, 2022	37B	—	—	-1.7B	-4.58%	-0.41	—	+23.45%	-3.50%	-14.92%
Jul 4, 2022	45.1B	—	—	-953.8M	-2.12%	-0.15	—	+22.28%	-1.06%	-4.77%
Jan 3, 2023	54.2B	—	—	-158.7M	-0.29%	0.14	—	+21.19%	+0.82%	+3.88%
Jul 3, 2023	60.4B	—	—	776.4M	+1.29%	0.61	—	+21.79%	+3.21%	+14.75%
Jan 2, 2024	59.2B	—	—	726M	+1.23%	0.76	—	+22.18%	+4.04%	+18.22%
Jul 2, 2024	59.3B	—	—	853.2M	+1.44%	0.90	—	+22.58%	+4.78%	+21.19%
Jan 6, 2025	63.1B	—	—	1.3B	+2.00%	1.43	—	+22.88%	+7.16%	+31.27%
Jul 7, 2025	70.3B	—	—	2.4B	+3.45%	1.60	—	+23.80%	+7.25%	+30.46%
Jan 5, 2026	79.7B	—	—	4.1B	+5.16%	1.82	—	+24.78%	+7.32%	+29.54%
Apr 28, 2026	10.2B	5.5B	6.2B	528.5M	+5.17%	0.23	0.17	+24.78%	+7.32%	+29.54%